TrialThe British journal of dermatology2021

Long-term efficacy of certolizumab pegol for the treatment of plaque psoriasis: 3-year results from two randomized phase III trials (CIMPASI-1 and CIMPASI-2).

K B Gordon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.